ARTICLE | Clinical News
Eniluracil: Phase I/II suspended enrollment
November 24, 2008 8:00 AM UTC
Adherex closed enrollment in a dose-escalation, Asian Phase I/II trial after a reprioritization of its development programs. The trial, which had enrolled 9 patients, is evaluating oral eniluracil in ...